Denemek ALTIN - Özgür
The Era Of Individualisation Has Only Just Begun
Express Pharma
|September 16-30, 2018
For todays generation of digital natives, the ability to personalise the products they buy is increasingly expected as a given. To keep pace, the makers of these products need highly flexible manufacturing systems that are at the same time efficient and profitable. This introduces a whole new set of demands on plant infrastructure. An insight by Carmen Klingler-Deiseroth, a freelance journalist
-
THE VARIETY of options available for customising mass-produced products continues to grow. It’s no longer limited to the usual suspects like breakfast cereals, cars and photo books. Particularly among the younger generation of digital natives, there is a growing desire to fine-tune every online purchase to match their individual tastes and preferences. “The era of individualisation has only just begun,” declares Robert Kickinger, Mechatronic Technologies Manager, B&R.
Profitable production in batches of one Batch-size-one production is nothing new, really. In fact, it’s standard practice in many craft businesses. “What is new, however, is the idea of making customised products under mass-production conditions,” asserts Kickinger. So far, this has proven difficult to implement in a way that is economically viable. That’s because any increase in system flexibility is usually accompanied by a reduction in overall equipment effectiveness (OEE). “When that happens, individualisation is no longer profitable.”
The goal of mass customisation is therefore to keep the three factors of OEE – availability, performance and quality – at a level consistent with what can be achieved in mass production. In addition, manufacturers seek to maximise their return on investment (ROI) and to minimise their time to market (TTM) for new and improved products. “This is the only way to make mass customisation viable from an economic perspective.”
Bu hikaye Express Pharma dergisinin September 16-30, 2018 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Express Pharma'den DAHA FAZLA HİKAYE
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
